Radiation-induced pulmonary arterial perfusion defects: modification by D-penicillamine

Area of Science:

• Radiology
• Pulmonary Medicine
• Pharmacology

Background:

• Radiation therapy can cause lung damage, affecting its function.
• D-penicillamine has previously shown benefits in improving lung tissue structure after radiation.
• The functional impact of D-penicillamine on radiation-induced lung injury requires further investigation.

Purpose of the Study:

• To evaluate the effect of D-penicillamine on lung function in a rat model of radiation-induced lung injury.
• To assess changes in pulmonary perfusion following irradiation and D-penicillamine treatment.

Main Methods:

• Male rats were exposed to 60Co gamma radiation.
• Half of the irradiated rats received daily D-penicillamine (10 mg/day).
• Lung perfusion scans were performed one to nine months post-irradiation to assess blood flow.

Main Results:

• Untreated irradiated rats showed hyperemia, hypoperfusion, and perfusion defects.
• D-penicillamine treatment delayed the onset and reduced the severity of perfusion defects.
• Penicillamine administration accelerated the recovery of pulmonary hypoperfusion.

Conclusions:

• D-penicillamine demonstrates a protective effect on lung function following radiation exposure.
• The drug improves arterial perfusion and mitigates radiation-induced lung injury in rats.
• Functional assessment supports D-penicillamine's role in managing radiation pneumonitis.